comparemela.com

Page 5 - Tom Russ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NHS not ready to dish out breakthrough Alzheimer s drug

Top doctors today warned that the NHS is not ready to dish out the medication, made by US-based pharmaceutical giant Eli Lilly, and needs to gear up now in preparation to do so.

United kingdomCity ofUnited statesRichard oakleySusan kolhaasTom russJohn hardyCharles marshallEli lillyAlzheimer research united kingdomResearch at alzheimer societyUniversity of washington school medicineFoundation trustAlzheimer scotland dementia research centreCentre for discovery brain sciencesUniversity of edinburgh

World on cusp of first generation of treatments for Alzheimer s

Almost half of those on donanemab had no clinical progression of disease at one year compared with 29 on a placebo, a study showed.

United kingdomEli lillyRichard oakleySusan kolhaasJohn hardyDaniel skovronskyCharles marshallTom russAlzheimer scotland dementia research centreAlzheimer societyUnited kingdom dementia research instituteAlzheimer research united kingdomUniversity college londonQueen mary university of londonClinical dementia rating scale sumResearch united kingdom

First generation of drugs to treat Alzheimer s slows cognitive decline

THE world is “on the cusp of a first generation of treatments for Alzheimer’s disease”, experts have said, as a new drug was found to slow…

United kingdomTom russHumza yousafSusan kolhaasCharles marshallJohn hardyEli lillyRichard oakleyDaniel skovronskyKing charlesAlzheimer research united kingdomUnited kingdom dementia research instituteQueen mary university of londonUniversity college londonAlzheimer scotland dementia research centreAlzheimer society

New dementia drug donanemab heralded as the beginning of the end of Alzheimer s

In half of patients, donanemab completely halted mental decline for more than a year

United kingdomCity ofEli lillyJohn hardyTom russRichard oakleyFoundation trustNeuroscience at university college londonUniversity college london hospitalsAlzheimer scotland dementia research centreAlzheimer societyProducts regulatory agencyNational institute for healthDrug administrationUniversity of edinburghMedicines healthcare

New Dementia Risk Score Predicts Dementia Probability

A newly developed risk score may help clinicians determine an individual s probability of dementia over 5, 9, and 13 years, allowing for more time to potentially intervene.

Tom russDavid curtisIvan koychevAlzheimer scotland dementia research centre in edinburghSecond affiliated hospital of nanchang universityUniversity of oxfordLancet commissionScience media centreUniversity college london genetics instituteXi jian daiSecond affiliated hospitalNanchang universityMedscape medicalUnited kingdom biobankUnited kingdom basedUniversity college london

vimarsana © 2020. All Rights Reserved.